CVE-2024-53522

CVE-2024-53522 is a high-severity vulnerability with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-331.

Key facts

Description

Bangkok Medical Software HOSxP XE v4.64.11.3 was discovered to contain a hardcoded IDEA Key-IV pair in the HOSxPXE4.exe and HOS-WIN32.INI components. This allows attackers to access sensitive information.

Frequently asked questions

What is CVE-2024-53522?
Bangkok Medical Software HOSxP XE v4.64.11.3 was discovered to contain a hardcoded IDEA Key-IV pair in the HOSxPXE4.exe and HOS-WIN32.INI components. This allows attackers to access sensitive information.
How severe is CVE-2024-53522?
CVE-2024-53522 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2024-53522 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (50th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2024-53522?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2024-53522 have an EU (EUVD) identifier?
Yes. CVE-2024-53522 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-51986.
When was CVE-2024-53522 published?
CVE-2024-53522 was published on 2025-01-07 and last updated on 2026-07-05.

References

EU advisories (EUVD)

Other CWE-331 vulnerabilities

Browse all CWE-331 vulnerabilities →